IL33 and neoplasm: The immunoreactivity of IL-33 was not associated with the TNM stage or the degree of differentiation, however, recent studies show an association between IL-33 expression in the tumor epithelium of metastatic CRC and a shorter survival, suggesting that the tumor IL-33 expression is clinically important in CRC progression (37).